How to Manage Impact of Coronavirus (COVID-19) for Global Pharma and Biotech Continuity Register

May 22, 2020 - DE US

compliance key

Topic :How to Manage Impact of Coronavirus (COVID-19) for Global Pharma and Biotech ContinuityRegister : Coupon : Use this Coupon (NEW2COMPLIANCE) and get (10% Off) On New SignupOverview:Attend this webinar to understand how the COVID-19 pandemic can affect manufacturing operations, employee safety and how to be flexible and creative in these uncertain times when it comes to business continuity.Areas Covered in the Session :Background - How did this become a pandemic?Employee Engagement / InteractionImpact to IT systemsFacilities Impact to WorkforceSupply Chain / DistributionSpeaker:Dr. Ginette M. Collazo is Keynote Speaker at ComplianceKey. She is Nine years ago she established Ginette M. Collazo, LLC. A USA based boutique consulting type that provides services in very specialized areas. Dr. Collazo is one of the few Human Error Reduction Experts in the world. Her firm created a methodology for human error investigations, root cause determination, CA-PA development, and effectiveness, and it as been implemented around the world. Ginette has also applied the methodology in complex scenarios and disasters, like the BP oil spill, offshore drilling, Navy, Chevron explosion investigation, and other industries besides GMP regulated environments.Contact Info :Compliancekeyhttps://www.compliancekey.usEmail : support@compliancekey.usPhone : +1 717-208-8666

More Information